Biomarkers for deliriuma - A review

Babar A. Khan, Mohammed Zawahiri, Noll L. Campbell, Malaz A. Boustani

Research output: Contribution to journalReview article

57 Scopus citations


To improve delirium recognition and care, numerous serum biomarkers have been investigated as potential tools for risk stratification, diagnosis, monitoring, and prognostication of delirium. The literature was reviewed, and no evidence was found to support the clinical use of any delirium biomarker, although certain biomarkers such as S-100 beta and insulin-like growth factor-1 and inflammatory markers have shown some promising results that need to be evaluated in future studies with appropriate sample size, prospective designs, and in a more-generalizable population.

Original languageEnglish (US)
Pages (from-to)S256-S261
JournalJournal of the American Geriatrics Society
Issue numberSUPPL. 2
StatePublished - Nov 1 2011


  • biomarkers
  • delirium
  • serum

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Biomarkers for deliriuma - A review'. Together they form a unique fingerprint.

  • Cite this